Phibro Animal Health | PAHC - بدهی های جاری





بدهی های جاری تغییر دادن تاریخ
Align Technology USD 1.92B 46.45M 2025-12
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Henry Schein USD 3.23B 79M 2025-12
Idexx Laboratories USD 1.15B 103M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Pacira USD 120.59M 13.51M 2025-12
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Zoetis USD 2.24B 428M 2025-12